Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRODIGE 21: Sorafenib and Pravastatin in Child B HCC
NCT01357486Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Nov 2011
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib, pravastatin in hepatocellular carcinoma (HCC), sponsored by Centre Hospitalier Universitaire de Bordeaux. Started Nov 2011; status: completed.
02
Drugs
sorafenibpravastatin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT01357486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01357486.